Most frequently asked questions and answers about Human Solid Plasma technology.
General Questions
PRP (Platelet-Rich Plasma) is platelet-rich liquid plasma; HSP is a semi-solid protein matrix obtained by controlled heat denaturation of plasma proteins (especially albumin). While PRP relies on the liquid effect of growth factors, HSP additionally provides volume and micro-regenerative stimulation.
No. HSP is not a synthetic filler alternative; it is a biological matrix approach obtained entirely autologously (from the patient's own blood). It does not contain synthetic materials like hyaluronic acid, collagen, or similar.
Yes. Human Solid Plasma is an invention technology registered by the Turkish Patent and Trademark Office.
HSP's duration of effect varies according to the area applied, tissue characteristics, patient age/health condition, and application protocol. Giving a general duration is not appropriate; the physician plans the expected duration for the patient during clinical evaluation.
Safety and Side Effects
Thanks to its autologous structure, the risk of allergic reaction with HSP is quite low. As with every injection procedure, general injection symptoms such as local redness, mild swelling, or temporary sensitivity may be seen. These symptoms generally regress in a short time.
In patients with active infection, coagulopathy (clotting disorder), during pregnancy, with known plasma protein disorders, or with active skin disease in the application area, individual physician evaluation is essential.
It is generally not recommended for routine use during pregnancy and breastfeeding. Consult your physician for individual situations.
It varies according to the application area and protocol. In many dermatological/aesthetic applications, topical anesthesia may be sufficient.
Application Process
HSP is prepared with a 6-step protocol: blood collection → centrifugation → plasma separation → loading the HSP device → controlled heat denaturation → output ready for physician.
The total visit duration includes preparation and application phases and depends on clinical conditions. The process is designed to integrate into the daily clinical workflow.
This varies according to the application area and clinical goal. While some aesthetic applications are evaluated with a single session, chronic wound support or gynecological regenerative protocols may generally include multiple sessions.
Clinic and Distributorship
Physicians and clinic owners can contact us via our contact form to get detailed information about the HSP device and protocol.
Yes. Training is planned for the use of the HSP device and protocol.
Yes. HSP has the relevant quality and conformity certificates. The certificate logos (ISO, CE, Turkish Patent) at the bottom of the page reflect this.
You can submit your request via our contact form with the title "Distributorship".